SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0000950123-05-011915
Filing Date
2005-10-06
Accepted
2005-10-06 14:32:19
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-4 y12516a1sv4za.htm S-4/A 1636334
2 EX-23.1: CONSENT OF KPMG LLP y12516a1exv23w1.htm EX-23.1 2554
3 EX-23.2: CONSENT OF ERNST & YOUNG LLP y12516a1exv23w2.htm EX-23.2 1744
4 EX-99.1: FORM OF PROXY CARD y12516a1exv99w1.htm EX-99.1 42282
5 EX-99.2: CONSENT OF MERRILL LYNCH PIERCE FENNER & SMITH INCORPORATED y12516a1exv99w2.htm EX-99.2 4610
7 GRAPHIC y12516a1y1251604.gif GRAPHIC 1905
8 GRAPHIC y12516a1y1251601.gif GRAPHIC 1937
9 GRAPHIC y12516a1y1251603.gif GRAPHIC 1012
10 GRAPHIC y12516a1y1251600.gif GRAPHIC 1905
  Complete submission text file 0000950123-05-011915.txt   1698968
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: S-4/A | Act: 33 | File No.: 333-128446 | Film No.: 051126954
SIC: 2835 In Vitro & In Vivo Diagnostic Substances